IPIX .. let me reiterate the issue of ftds on an OTC

New Post Public Reply Private Reply Replies (1) Message Board
4kids 4kids #4115
226
IPIX .. let me reiterate

the issue of ftds on an OTC stock is bogus because there are plenty of OTC stocks currently on reg sho who NR *reports* FTDs on .. it's irrelevant .. the only aspect that *imo* matters when it comes to OTC targets surviving NRs' attn .. is said OTC mgmt's *awareness* .. i know for a fact that there are more than a few actual Innovation Pharma investors .. who remained investors .. based on mgmt's aggressive response re: the *efforts* of 2015 ..

again NR works cycles of money (they can abusively short at will to *allegedly* make a market but the accountability factor is nil as was noted by what NR *reported* recently re: legal on IPIX specific to daily volume avgs running 700k .. as if ) .. 99% of those companies won't survive .. the ones that do *imo* are epic in how handled ..

NR *imo* is between a rock and a very hard place specific to IPIX *shares* .. volume doesn't decrease when there are sells of significance .. relentless PPS compression aligned with decreasing volume (in since 2015's *avg* of 500k) .. indicates a *stuck* NR UPSIDE DOWN .. and it's not unique to IPIX .. imo like a few others .. an OTC Survivor

btw the post alan posted was to show to just what lengths NR goes when UPSIDE DOWN .. the difference between that targeted OTC stock and IPIX (CTIX) .. is that company came public via an S1 reg in April 2015 .. and has triggered 10 rounds (currently) via reg sho .. there is clearly a difference of how NR *reports* those companies like Innovation Pharma that came public via a R/M years back .. and those companies who didn't

as for the tired *argument* that new eyes won't enter .. bullshit .. anyone who enters an OTC stock without doing their DD .. needs that lesson learned .. there is no financial advisor in the US who will advocate for an equity that trades below $5.00 .. regardless of where *traded*

OTC investors do their DD .. and imo the majority who *outlast* NRs' efforts .. are fully cognizant of their own risk tolerance re: risk and potential reward

4kids


Quote:

I usually delete/don't read your posts regarding the NS issue, and I seldom respond, at least not lately. Why are there ANY ftd's? Isn't that illegal? Why do we have any at all if it is not legal ??? Why is our stock price manipulated to the level that it is??? This is not free market trading, and you know it. I don't give 2 shits if this scares off new investors or not. The fact is that our share price has been/is being manipulated by those whose interests lie in the SP being where it is now. I am a rube when it comes to investing in OTC bio stocks, but I know enough to call it when I see it.
New people thinking about getting in here: why wouldn't you? Don't risk anything more that you are willing to lose. We've all made our bets on this one. The bashers don't own any shares. Don't listen to them. They're liars and thieves. LIARS AND THIEVES.



Read More: https://investorshangout.com/post/view?id=517...z5OXMrR0Bx

Read More: https://investorshangout.com/post/view?id=517...z5OlcEVYCM
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Behavioral Crisis Center Saves Mobile $101M Since 2021

Updated Category News Views 0

AltaPointe Saves Millions While Supporting Community Health Let's dig into this remarkable achievement by the AltaPointe Behavioral Health Crisis Center. Since opening its doors in May 2021, the Mobile, Alabama facility has notched up a mind-boggling $101.5 million in community savings. This isn’t merely about numbers on a ledger—it's about real human impact, better...

Continue Reading
Immunic Pushes Boundaries in MS with Vidofludimus

Updated Category News Views 1

Shaking Things Up in Multiple Sclerosis Therapy There's no telling how often the biotech sector tosses around the term 'game-changer,' but when Immunic's name comes up, more ears are perking up these days. The New York-based firm, waving the Nasdaq: IMUX flag, is lining up a virtual shindig come September 9, 2026, and for anyone invested in multiple sclerosis (MS) or...

Continue Reading
Replay Sports Cards Expands to Greenville With New Franchise

Updated Category News Views 0

An Old Hobby Gets New Life in Greenville Isn't it something when a hobby from your childhood eventually morphs into a business venture? That's exactly what's happening in Greenville, North Carolina, where Replay Sports Cards is laying down roots. Thanks to Jim and Jake Whitehurst's fresh franchise agreement, the card community along the eastern seaboard is about to have a...

Continue Reading
Lindian's Bold Leap into Rare Earths Processing

Updated Category News Views 0

Changing the Game in Rare Earths When Lindian Resources announces a partnership, it's not just window dressing. This time, they've linked arms with Carester SAS for a hefty venture into oxide separation. The scope? An 8,000-tonne REO facility in Kazakhstan, a place already stamped as a geological treasure chest. We're staring at what could potentially be a new dawn for...

Continue Reading
Plan A Bets on AI in High-Stakes M&A Arena

Updated Category News Views 0

Digging Deeper with AI in M&A Deals Picture this: you’re at the table with a fat corporate M&A deal, eyes darting as you decipher numbers and nods, when out swings Plan A Technologies with their new ace up their sleeve—a stealth AI assessment tool armed to sharpen their technical due diligence. Unmasking the Tech Jigsaw Las Vegas-based Plan A Technologies hasn't just...

Continue Reading
BlueSky Enters Nashville: In-Home Vet Care Begins

Updated Category News Views 3

Nashville Welcomes A New Wave of Pet Care In a world where convenience is king, BlueSky At-Home Veterinary Care is stepping up to the plate—or should I say, doorstep—by rolling out its fresh take on veterinary services in Nashville. Kicking off on September 15, 2026, this isn't just any ol' run-of-the-mill clinic opening. We're talking about vets coming straight to...

Continue Reading
Nanochon Tests Innovative Knee Implant in Human Trial

Updated Category News Views 0

Mending Knees with New Tech: The Chondrograft™ Debut Picture this: Nanochon's Chondrograft™ just hit the ground running. They've got a bite out of the future by diving headfirst into their First-in-Human (FIH) clinical study. This ain't your grandma's knee replacement talk. This is about changing the game for those knee cartilages that let out a groan every time you...

Continue Reading
Herzog Joins Greenberg Traurig: A Litigation Powerhouse

Updated Category News Views 0

Greenberg Traurig Welcomes David M. Herzog to the Team Ah, the rat race of litigation just got a bit fiercer with Greenberg Traurig's latest acquisition: David M. Herzog. This isn’t just another lawyer joining the ranks; Herzog's a dynamo, coming in hot from the U.S. Attorney's Office, right onto the battlefield of corporate litigation. Why Herzog's Move Matters...

Continue Reading
Tradr's Bold Venture: Anthropic ETFs Ahead of IPO

Updated Category News Views 2

Why Tradr Is Diving Into Anthropic's Hype There's a whiff of anticipation in the air as Anthropic gears up for its much-anticipated IPO, and Tradr isn't sitting on its hands here. They've just filed for two ETFs—one long, one short—ahead of the big day. We're talking about ANTT and ANTZ, betting on leveraged and inverse plays on whatever whirlwind Anthropic's stock...

Continue Reading
Geron Faces Legal Woes: Investors Watch for Fallout

Updated Category News Views 1

Legal Storm Brewing Around Geron Corporation Ah, the familiar smell of trouble in corporate paradise, and this time it's drifting from Geron Corporation (NASDAQ: GERN). If you've got your chips on the table with these guys, you'd better pony up and listen up. Kuehn Law, PLLC is lighting a fire under Geron's board, snooping on whether their head honchos scuttled their...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Seek Justice in Metagenomi, Inc. Class Action Lawsuit

Updated Category News Views 45

Opportunity for Investors in Metagenomi, Inc. Securities Case Investors are presented with a significant opportunity as The Schall Law Firm steps forward to announce the initiation of a class action lawsuit against Metagenomi, Inc. (MGX). This action follows allegations of violations pertaining to federal securities laws made by the Company. Details on the Class Action...

Continue Reading
Latest Insights on Riksbank Certificate Auction Results

Updated Category News Views 229

A Closer Look at the Riksbank Certificate Auction The recent certificate auction conducted by the Riksbank has caught the attention of both investors and analysts. This event plays a vital role in managing liquidity and signaling the intentions behind monetary policy. The latest auction provided crucial figures that shed light on the current state of the economy. Overview...

Continue Reading
Understanding the Bullish Momentum Behind Meta Platforms

Updated Category News Views 104

Understanding the Bullish Momentum Behind Meta Platforms Meta Platforms (NASDAQ:META) has experienced an extraordinary surge in stock performance this year, yielding over 26% in total returns so far. This positive trajectory places it favorably among its peers in the Magnificent Seven, right behind NVIDIA’s impressive 30% climb. Such momentum can largely be attributed...

Continue Reading
Kamala Harris and Donald Trump in a Tight Race: Poll Insights

Updated Category News Views 78

Tight Race Between Candidates Revealed in Poll The latest polling data showcases an exciting contest in the presidential race. Vice President Kamala Harris holds a slight edge with 48% support from likely voters, while former President Donald Trump is close behind at 47%. This intense competition not only grabs attention but also highlights both candidates' distinctive...

Continue Reading
Rail Vision Unveils D.A.S.H. Platform, Elevating Rail Safety and Efficiency

Updated Category News Views 279

Rail Vision Launches Innovative D.A.S.H. SaaS Platform Rail Vision Ltd. (Nasdaq: RVSN), a pioneer in advancing railway safety and data-driven insights, has announced the launch of its latest Software as a Service (SaaS) platform named D.A.S.H. This platform represents a significant step forward in how rail operators can enhance safety and operational efficiency. D.A.S.H.:...

Continue Reading